EP2987142A1 - Systems and methods for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue - Google Patents
Systems and methods for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissueInfo
- Publication number
- EP2987142A1 EP2987142A1 EP14736060.6A EP14736060A EP2987142A1 EP 2987142 A1 EP2987142 A1 EP 2987142A1 EP 14736060 A EP14736060 A EP 14736060A EP 2987142 A1 EP2987142 A1 EP 2987142A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cells
- sub
- cellular
- units
- expression levels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
- G06V20/695—Preprocessing, e.g. image segmentation
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10064—Fluorescence image
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30024—Cell structures in vitro; Tissue sections in vitro
Definitions
- Embodiments relate generally to analysis of digital images, and more particularly, to analysis of digital images of biological tissue samples.
- segmentation refers to the identification of boundaries of biological units, such as cells, within a digital image. These boundaries separate each individual unit from others.
- the digital image may be obtained using a microscope.
- a watershed transform is one image processing technique that has been used for segmenting images of cells.
- a digital image may be modeled as a three-dimensional topological surface, where values of pixels (e.g., brightness or grey level) in the image represent geographical heights.
- a weak segmentation algorithm may not produce an accurate segmentation without significant adaptation and optimization to specific tissue type applications.
- a weak segmentation algorithm may cause the image to be over-segmented (e.g., what appears as a single cell may actually be only a portion of a cell) or under-segmented (e.g., what appears as a single cell may actually be several different cells in combination).
- the image may not be properly segmented with a weak segmentation algorithm, in part, because a suitable segmentation parameter for one region of the image may not work well in other regions of the same image. Therefore, a weak segmentation algorithm may not be robust enough for segmentation of large numbers of cells having many morphological variations.
- a weak segmentation algorithm may not be robust enough for segmentation of large numbers of cells having many morphological variations.
- Wang et al. proposed a method for cell segmentation and cycle estimation using an individual channel. In general, such method is based on machine learning methods using support vector machines from segmented images.
- a method for cell segmentation was generally proposed based on nuclei and cytoplasm markers, where each cell has one nucleus. Nuclei segmentation was performed by selecting a global threshold value, and using the watershed algorithm. Once the nuclei regions were segmented, they were used as seed regions to segment the cytoplasm by applying the watershed algorithm.
- a method for quantification of sequential immunofluorescence staining was proposed in Wahlby et al. This method is generally based on the quantification of the immunofluorescence staining only in the nuclei, where nuclei segmentation is a semiautomatic process, which involves human intervention.
- a statistical method for nuclei segmentation was proposed. This method typically includes defining a likelihood function, and to separate touching nuclei as a mixture of Gaussians distributions.
- the present disclosure provides advantageous systems and methods for the analysis of digital images.
- the present disclosure provides for improved systems and methods for the analysis of digital images of biological tissue samples.
- the present disclosure provides for a computer-implemented method for performing hierarchical image segmentation analysis of sub-cellular units in biological tissue, the method including accessing image data corresponding to multi-channel multiplexed image of biological tissue sequentially fluorescent stained to manifest expression levels of a plurality of morphological biomarkers in the biological tissue, performing multi-channel image segmentation analysis on the image data based on the biomarker expression levels to identify locations and configurations of one or more cells in the biological tissue, performing multi-channel image segmentation analysis on the image data based on the biomarker expression levels to identify locations and
- configurations of one or more sub-cellular morphological units within the one or more cells rendering, on a visual display device, a hierarchical representation of the one or more cells and the one or more sub-cellular morphological units in the one or more cells.
- the present disclosure provides for a computer system for performing multichannel hierarchical image segmentation analysis of sub-cellular units in biological tissue
- the computer including a visual display device, a processing device, and a storage device.
- the processing device is configured to access multi-channel image data corresponding to a multiplexed image of biological tissue sequentially fluorescent stained to manifest expression levels of a plurality of morphological biomarkers in the biological tissue, perform multi-channel image segmentation analysis on the image data based on the biomarker expression levels to identify locations and configurations of one or more cells in the biological tissue, and perform image segmentation analysis on the image data based on the biomarker expression levels to identify locations and configurations of one or more sub-cellular morphological units within the one or more cells.
- the storage device is configured to store the locations and configurations of the one or more subcellular morphological units within the one or more cells.
- the present disclosure provides for a one or more computer-readable media having encoded thereon one or more computer-executable instructions for performing a method for performing multi-channel hierarchical image segmentation analysis of subcellular units in biological tissue, the method including accessing image data
- expression levels of a biomarker in the one or more cellular morphological units at cell level can be automatically determined and expression levels of a biomarker in the one or more sub-cellular morphological units at the level of the sub-cellular morphological units can be automatically determined.
- a plurality of biological tissue regions can be automatically grouped based on the expression levels of the biomarker in the sub-cellular
- an analysis to determine a relationship between expression levels of a biomarker in the one or more sub-cellular morphological units and the configurations of the one or more sub-cellular morphological units can be performed .
- the one or more sub-cellular morphological units include one or more nuclei, one or more cytoplasms, and/or one or more membranes.
- the one or more sub-cellular morphological units include a membrane or a cytoplasm
- the image segmentation analysis can identifies the membrane or cytoplasm by using a probability map to generate a ring-like structure modeling the membrane or the cytoplasm.
- representations of expression levels of a biomarker can be rendered on a visual display device in an overlaid manner on the representations of the one or more cells and the one or more sub-cellular morphological units in the one or more cells.
- a measure of expression levels of a biomarker can be determined.
- the measure can be specific to at least one of the one or more sub-cellular morphological units in the one or more cells.
- the measure of the expression levels of the biomarker can be a mean of the expression levels.
- the locations and configurations of the one or more subcellular morphological units can be determined by imposing topological constraints within the cells.
- the plurality of morphological biomarkers include a plurality of biomarkers representative of a single type of sub-cellular morphological unit.
- image segmentation analysis is performed on the image data based on the biomarker expression levels and biomarker morphology to identify at least one tissue-based region of interest and a hierarchical representation of the one or more cells, the one or more sub-cellular morphological units in the one or more cells, and the at least one tissue-based region of interest can be rendered on a visual display device.
- the one or more sub-cellular morphological units include at least one of cell membranes of the one or more cells, cytoplasms of the one or more cells, and nuclei of the one or more cells and a hierarchical representation of the one or more cells, the at least one tissue-based region of interest, the at least one of the cell membranes of the one or more cells, the cytoplasms of the one or more cells, and the nuclei of the one or more cells can be rendered on a visual display device.
- the at least one tissue-based region of interest includes a collection of stromal cells or a collection of epithelial cells.
- shapes of the one or more cells based on the image segmentation analysis identifying the locations and the configurations of the one or more cells can be determined and the one or more cells, sub-cellular units based on the shapes of the one or more cells, or sub-cellular units can be ranked. Each ranking can indicate a probability or similarity that cell boundaries, or sub-cellular units of a corresponding cell or sub-cellular unit are correctly identified by the image segmentation analysis.
- a pixel of the image data is associated with a single type of sub-cellular morphological unit is provided in the hierarchical representation.
- a pixel of the image data with one or more types of sub-cellular morphological unit is provided in the hierarchical representation.
- the pixel of the image data with a first probability that the pixel corresponds to the first type of sub-cellular morphological unit and a second probability that the pixel corresponds to the second type of sub-cellular morphological unit is provided in the hierarchical representation. In some embodiments, the pixel of the image data with a first membership value that the pixel corresponds to the first type of sub-cellular
- one or more segmentation-quality metrics can be determined for the one or more cells.
- the one or more segmentation-quality metrics for the one or more cells can be rendered on a visual display device in an overlaid manner over the rendering of the one or more cells.
- rendering of the multi-channel hierarchical representation of the one or more cells includes only rendering a subset of cells among the one or more cells having segmentation-quality metrics that satisfy one or more predefined
- multi-channel image segmentation analysis can be performed on the image data based on the biomarker expression levels to identify locations and configurations of one or more tissue-types in the biological tissue.
- FIGS. 1A-E depict images/schematics of multiplexing images and joint segmentation, according to exemplary embodiments of the present disclosure
- FIG. 2 is a flow diagram illustrating a segmentation process in accordance with exemplary embodiments of the present disclosure
- FIGS. 3A-C depict images of image flattening according to exemplary embodiments of the present disclosure
- FIGS. 4A-B depict other images of image flattening
- FIGS. 5A-C depict images of individual nuclei, membrane and nuclei and membrane
- FIGS. 6A-C depict images of nuclei segmentation only from the nuclei channel
- FIGS. 7A-B depict images of membrane detection according to exemplary embodiments of the present disclosure
- FIGS. 8A-E depict images of hierarchical joint segmentation at the sub-cellular level, according to exemplary embodiments of the present disclosure
- FIG. 9 depicts the representation and abstraction of an exemplary tissue architecture at the sub-cellular level as a tree data structure
- FIG. 10 is an example of the proposed tissue representation depicted in FIG. 9;
- FIG. 11 is a diagram showing hardware and software components of an exemplary system capable of performing the processes of the present disclosure
- FIG. 12 is an exemplary client-server environment for implementing the systems and methods of the present disclosure
- FIGS. 13A-F depicts images of individual cell analysis from Xenograft datasets
- FIGS. 14A-F depict images of the segmentation results of individual cell analysis in the epithelium
- FIGS. 15A-I depict a comparison of Xenograft images and segmentation result images according to exemplary embodiments of the present disclosure
- FIGS. 16A-I depict another comparison of Xenograft images and segmentation result images according to exemplary embodiments of the present disclosure
- FIGS. 17A-C depict images from a prostrate cancer study according to exemplary embodiments of the present disclosure
- FIGS. 18A-B depict images of biomarker quantifications according to exemplary embodiments of the present disclosure.
- FIG. 19 depicts an image showing the biomarker quantification and localization at the sub-cellular level, according to exemplary embodiments of the present disclosure.
- the present disclosure provides advantageous systems and methods for the analysis of digital images. More particularly, the present disclosure provides for improved systems and methods for the analysis of digital images of biological tissue samples.
- tissue analysis does not account for tissue analysis, grouping and quantification of tissue sections in terms of sub-cellular compartments (e.g., nuclei, membrane and cytoplasm).
- sub-cellular compartments e.g., nuclei, membrane and cytoplasm.
- Such existing approaches focus in nuclei segmentation using information derived from only one channel.
- morphological biomarkers that provide structural descriptors of the tissue architecture at the sub-cellular level have not been used to group, quantify and correlate individual and cell populations to discover complex biomarker networks within cell populations.
- Exemplary embodiments of the present disclosure provide for: i) segmenting, ii) grouping, and iii) quantifying molecular protein profiles of individual cells in terms of sub-cellular compartments (e.g., nuclei, membrane, and cytoplasm).
- Exemplary embodiments advantageously perform tissue segmentation at the sub-cellular level to facilitate analyzing, grouping and quantifying protein expression profiles of tissue in tissue sections globally and/or locally.
- tissue segmentation advantageously enables, for example, correlation of spatial and molecular configuration of cells with molecular information of different types of cancer.
- joint segmentation of cellular entities and their compartments can be performed based on registered sequentially stained fluorescent images.
- Exemplary embodiments of the present disclosure can take advantage of contextual information expressed in the sequentially stained images to segment and quantify tissue both globally and locally in terms of sub-cellular compartments e.g., nucleus, membrane and cytoplasm.
- Exemplary embodiments can: (i) impose topological constraints in a hierarchical structure to correctly segment sub-cellular compartments, (ii) group individual cells according to specific criteria, and/or (iii) quantify groups of cells based on corresponding biomarker protein expression at the sub-cellular level.
- Each individual cell has a substantially semicircular/ elliptical shape and it may be composed by none, any or all of the three regions: nuclei, membrane and cytoplasm, and where each region is a subcellular compartment.
- Hierarchical relationship For each sub-cellular compartment, the following hierarchy relationship holds: i) the nuclei is at the center of the cell, and is surrounded by the cytoplasm, and ii) the membrane is the located at the border of the cell and surrounds the cytoplasm.
- morphological unit refers to different cellular or sub-cellular structures, including, for example, nuclei, cytoplasm, and membrane.
- the exemplary systems/methods of the present disclosure include a hierarchical top-down approach to cell segmentation.
- the top-down approach first, individual single cell boundaries are segmented, and then individual sub-cellular compartments are imposed with topological constraints within the cell, so that hierarchical relationships are valid.
- multi-channel segmentation processes can be performed using multiplexed images of biological tissue.
- a multiplexed image typically consists of "N" number of channels of the same tissue section, where each channel provides a detailed and unique protein expression profile of the tissue of interest, thereby describing, for example, both the morphology and molecular composition of cancer tumors.
- tissue quantification at both the molecular and morphological level is possible by applying image analysis methods to multiplexed imaging in tissue micro-arrays.
- Some of the problems of individual cell analysis of tissue in multiplexed imaging can include the following challenges associated with individual cell
- Individual cell segmentation challenges can include: i) finding the association rule that maps every pixel in the multiplexing image to each individual cell, ii) finding the association rule of each pixel within the subcellular compartments corresponding to each individual cell (e.g., the association rule of each pixel and the nuclei, membrane and cytoplasm for a given cell), iii) finding a membership function that maps every pixel within the sub-cellular compartments corresponding to each individual cell (e.g., the membership function of each pixel and the nuclei, membrane and cytoplasm for a given cell)
- grouping rules can be according to: i) spatial relations (e.g., cells that belong to the epithelium region, or tissue organs), ii) morphological relationships among cells (e.g., cells that are circular versus cells that resemble ellipses), and/or iii) image segmentation quality, where those that are based on inclusion-exclusion rules (e.g., cells for which the membrane is surrounding the complete cell border).
- individual cells are not regular circular objects, but rather can have elliptical shapes.
- nuclei Absence of nuclei. Individual cells may not have a nucleus well defined or present at all, given that some tissue samples have a thickness of about 5mm. In this regard, cells that are not cut correctly by the middle, the two dimensional image may not intersect the cell-nuclei, and still the region can define an individual cell. This is due to orientation of the cut with respect to the cell.
- Image noise can affect the quality of the image at the global and/or local level.
- the non-uniform distribution of the fluorescent dyes and the effects of auto-fluorescence of the tissue may produce regions which contain high levels of artifacts.
- tissue multiplexing imaging is not to capture the entire bandwidth of the signal (similar to satellite imaging) but rather, to capture substantially all available contextual information with the means of molecular fluorescent probes that label specific cellular compartments or tissue organs (blood vessels, etc.).
- An example of contextual information is the intracellular spatial relations of sub-cellular compartments, where the nucleus is the cell's center, the membrane is at the cell's border, and the cytoplasm is between the membrane and the nuclei.
- information of additional channels can be integrated. For example, by integrating protein markers that bind to specific tissue types such as blood vessels, this can provide unique and relevant information to group individual cells for tissue architecture analysis.
- the channels Given "Z" number of distinct channels, the channels can be grouped as structural and morphological protein markers, so that there are “P” and "M” number of protein and morphological channels, respectively.
- the compound image T can be defined as the vector- value function with Z number of channels or features as:
- T(x, y) [J ! (x, y), - - - , I N (x, y)] , (x, y) e ⁇ .
- T can be written in terms of the individual channels as:
- the morphological channels T S,tructural consist of three or more different channels that provide structural information of the tissue in terms of: nuclei: T i
- g , gM, gc are different vector-value functions which map the corresponding nuclei, membrane and cytoplasm channels into a single channel.
- T C++ is a three-channel imag ⁇ e containing the oprtimal structural representation of the tissue architecture.
- FIGS. 1A-E depict images/schematics of multiplexing images and joint segmentation, according to exemplary embodiments of the present disclosure.
- FIG. 1A depicts a tissue core with different degrees of cancer.
- FIGS. 1B-D the images corresponding to T Compartments (derived from the structural markers) and the corresponding f segmentation function which maps the corresponding pixels into nuclei, membrane and cytoplasm are shown.
- FIG. IE schematics corresponding to different protein markers T Profein for the same tissue spot is shown.
- FIG. 1 presents images of a tissue sample with the corresponding o rptimal structural T C Economicsompart ,ment ,s and r protein markers T p r ot ,ei .n .
- O rptimal structural markers shown in different colors represented by cross-hatching in FIG. l(e.g., orange/red, green and blue), and represent membrane structures 104, cytoplasm structures 102 and nuclei structures 100, respectively.
- Protein markers T Protein are shown in FIG. IE.
- this formulation allows assigning each pixel (x, y) e I c to the unique cell and the specific compartments.
- One advantageous case of the previous formulation is binary segmentation.
- information contained in the different channels T C Economicsompart ,ment ,s is com rplementary J with res rpect to each other, ' and it is used by J the segmentation function f Segmentation Compartments ) ⁇
- An example of such used is specific cell morphological configuration.
- f Quantification is a function that maps the values from the protein image T Profei elect at the specific cell, and at the sub-cellular compartments defined by f S.egmentation .
- An example of functions for J f n Quantificat .i.on can be the mean,' and standard deviation among o others.
- f Quantification can represent probability distributions of the protein with respect to a given compartment.
- Images were acquired with an Olympus Microscope from: i) a representative dataset of tissue samples with different degrees of prostate cancer, and ii) Xenograft images.
- Typical Biomarkers of interest include, without limitation: DAPI, CFP3, S6, pS6, DAPI, CFP4, Glul, pCad, CFP5, pCREB, Ki67,pS6235, CFP6, AF_pCREB, AF_Ki67, CFP7, FOX03a, NaKATP, CFP8, pAkt, Keratin, CFP9, and pGSK3beta.
- each individual cell has a substantially semicircular/elliptical shape and is composed by three regions: nuclei, membrane and cytoplasm, and where each region is a sub-cellular compartment; and (ii) hierarchical relationship: for each sub-cellular compartment, the following hierarchy relationship holds: a) the nuclei is at the center of the cell, and is surrounded by the cytoplasm, and b) the membrane is the located at the border of the cell and surrounds the cytoplasm.
- the systems/methods of the present disclosure include a hierarchical top-down process (FIG. 2). In the top-down process, first, individual single cell boundaries are segmented, and then individual sub-cellular compartments are imposed with topological constraints within the cell, so that hierarchical relationships are valid.
- FIG. 2 is a flow diagram illustrating a top-down segmentation process 200 in accordance with exemplary embodiments of the present disclosure.
- multiplexed images of biological tissue can be retrieved from memory (e.g., non-transitory computer-readable media).
- the digital image may be obtained, for example, using a microscope and a camera.
- the target biological units in the digital image may include, but are not necessarily limited to, cells and/or sub-cellular
- Exemplary target cells may include, for example, i) epithelial cells and/or stromal cells, or ii) necrotic cells.
- biological unit refers to discrete biological structures and portions, components or combinations of biological structures in the digital image.
- a multiplexed digital image of biological tissue is enhanced to integrate information from different protein channels.
- individual cell segmentation is performed to discriminate between individual cells. For example, exemplary embodiments can identify individual cell by detecting the border or boundary of the individual cells. In some embodiments, supervised or unsupervised shape ranking and/or support vector segmentation can be used to identify cell borders in the digital image.
- tissue segmentation can be performed in the flattened image to discrimination between different tissue types before step 204. For example, tissue segmentation can be implemented to discriminate between, and classify cells as, epithelial cells, stromal cells, and/or necrotic cells.
- sub-cellular compartment segmentation is performed to discriminate between and classify different sub-cellular compartments. For example, exemplary embodiments can identify and classify sub-cellular compartments as nuclei, membrane, and/or cytoplasm.
- step 208 a hierarchical representation of the identified sub-cellular
- the hierarchical representation can include an expected location of the nuclei, cytoplasm, and membrane with respect to each other.
- cells are grouped based on
- a hierarchical representation of the tissue architecture is generated.
- the hierarchical representation can include images, graphics, and/or text to illustrate a hierarchy of the biological tissue in the digital image.
- the hierarchy relates to the relationships between the biological units in the image and can include levels, such as, a tissue level, cellular level, and/or a sub-cellular level.
- a tree data structure can be generated, which can be rendered as in a graphical form, as described in more detail below.
- Image enhancement improves the imaging quality of a specific compartment by integrating information from different protein channels with respect to the same subcellular compartment so that important information from different channels enhances the overall image specific marker.
- image flattening can be defined as a linear transformation, for which each channel in a composite image has a different mixing factor contributing to the overall enhanced image.
- the enhancement function for the membrane and cytoplasm markers can be expressed mathematically as: Membrane
- FIGS. 3A-C depict examples where the transformed enhanced image captures the whole tissue morphology globally and locally.
- the structural markers correspond to membrane markers, where high protein content is localized in the cell membrane (e.g., these markers enhance the cell border).
- FIG. 3A depict Na/K ATPase 202.
- FIG. 3B depict P-cadherin 204.
- FIG. 3C depict a color image that is a composite of the two protein markers: Na/K ATPase 202 (as shown in FIGS. 3 A and 3C) and P- cadherin 204 (as shown in FIGS. 3B and 3C).
- FIG. 3A shows a region with an image artifact 300
- FIG. 3B presents the corresponding region with no artifacts after enhancement
- FIG. 3C shows how these markers provide information needed to recover such artifacts.
- P-cadherin 304 are shown in FIGS. 3A and 3B, respectively.
- a composite image from the corresponding protein markers is shown in FIG. 3C. It is noted that by combining different markers, cases where image artifacts may exist can be corrected (e.g., FIG. 3C).
- FIG. 4A depicts a composite color image of two membrane protein markers: Na/K ATPase 404 (e.g., cross-hatching to represent pure red) and P-cadherin 402 (e.g., cross-hatching to represent pure green), respectively.
- FIG. 4B shows the corresponding transformed image g M ) as me resu lt of the enhancement process.
- the result of the image enhancement is an image that integrates the morphological information of both markers: Na/K ATPase 404 and P-cadherin 402.
- the combination of both protein markers delineates the epithelial cell membranes.
- Cell Segmentation Cell Border Detection
- cell segmentation can follow a top-down approach, where cells are first detected as a unit, and then, sub-cellular compartments are detected based on hierarchical constraints as discussed in more detail below.
- One challenge of segmenting each cell can be posed as detecting individual cell borders. The challenge in detecting cell borders is that there can be no clear and well defined boundary among cells, and cells must not overlap with each other. In the case where cells touch each other, there must exist a minimum distance of "one unit or pixel.”
- individual cell borders can be detected based on the transformed enhanced image g M (T ⁇ TM" e ) described herein.
- regions that correspond to local maxima also correspond to the "optimal" separation of two cells, while regions that correspond to local minima, correspond to the nuclei region.
- a variation of a watershed algorithm can be implemented, where regions of local minima are used as regions to delineate the cell borders by applying the watershed algorithm (see, e.g., Soille, Morphological Image Analysis, Springer- Verlag, Heidelberg, 2nd edition (2003)).
- regions of local maxima correspond to cell borders.
- Other examples of detecting individual cell borders are discussed in more detail in co-pending U.S. Patent Application Serial Nos. 13/666,343 and 13/657255, filed on November 1, 2012, October 22, 2012, respectively, the disclosure of which is incorporated by reference herein.
- a candidate nucleus is generated from the DAPI channel itself, and then, to correctly separate corresponding nuclei, a novel method, which penalizes the cell border estimated from the membrane marker, is used.
- FIGS. 5A-C depict examples of typical tissue where cells are touching each other.
- FIG. 5A depicts a DAPI channel of nuclei and membrane
- FIG. 5B depicts an enhanced image of nuclei and membrane
- FIG. 5C depicts a composite image of nuclei 502 and membrane 504.
- FIG. 5A presents the case where cells are poorly differentiated from the DAPI channel. Note that three cells: A,B, and C overlap with respect to each other (e.g., nuclei corresponding to cells A and B are overlapping with each other, making the difference of cells A and B difficult - similarly for cells B and C).
- FIG. 5B shows the same region with respect to the membrane channel. Note that cell discrimination is more evident as compared with the DAPI channel.
- FIG. 5C shows a composite of both, nuclei 502 and membrane channels 504 using cross-hatching to representing blue and red, respectively.
- the first method is based on detection of blob-like objects from a curvature metric constrained to a shape template, see Methods for segmenting objects in Images, International Application Number: PCT/SE2011/050407].
- the second method is based on Wavelet Analysis (Padfield et al., Spatiotemporal cell segmentation and tracking for automated screening, Biomedical Imaging: From Nano to Macro, ISBI 2008, 5th IEEE International Symposium, 376-379 (2008)).
- Wavelets decompose the images into different frequency channels, then de-noises the images in the wavelet coefficient space, and recombines relevant levels to yield segmented objects.
- Wavelets have several advantages for this application: they decompose the image in both the spatial and frequency domain enabling effective scale-space analysis, the calculation of wavelets across multiple scales is fast and computationally efficient, and the number of parameters can be limited or completely eliminated.
- an algorithm is utilized based on the shift-invariant wavelet frames transformation of the image, as well as the filtering of non-salient wavelet coefficients. Wavelet frames are identical to the standard wavelet transform except that the decimation operation at each level is omitted.
- the wavelet frames transform is robust to local noise variations and discards low frequency objects in the background.
- the signal term is approximated by thresholding the image stack with an Amplitude- scale-invariant Bayes Estimator (ABE) using Jeffreys' non-informative prior as an estimate of the significance of wavelet coefficients.
- ABE Amplitude- scale-invariant Bayes Estimator
- a correlation stack is computed, which is the multiplication of a subset of the de-noised wavelet coefficients corresponding to the selected scales.
- One of the advantages of the wavelet-based method for de-noising and segmentation is how it naturally represents objects at different scales.
- the selection of which scales to combine can be determined from the resolution of the images and the approximate expected object size.
- the subset of the channels used for the correlation stack are chosen to correspond with the scales at which the objects appear, thus ignoring scales containing only noise and those containing only low-frequency background information.
- the segmentation is then obtained as the extraction of connected regions in the correlation stack for coefficients greater than zero. Since the correlation stack emphasizes the frequencies corresponding to the objects, little post-processing is necessary to yield consistent filled shapes.
- This algorithm can detect objects even in the presence of relatively low contrast-to-noise and in the presence of slowly varying backgrounds (e.g., see FIG.
- FIGS. 6A-6C depict: (i) an original image (FIG. 6A), (ii) nuclei segmentation based on the wavelets based approach (FIG. 6B), and (iii) nuclei segmentation based on the shape-analysis based approach (FIG. 6C).
- the shape analysis approach assumes that nuclei cells have smooth but irregular convex shape such as a deformed ellipsoid.
- the method generally operates in two main steps. First, a watershed algorithm is used to find the cell nuclei regions. Watershed uses seed points that correspond to local minimum, where each seed point is found by applying morphological operations. In the second step, regions are merged. Merging criteria is a function of the magnitude of the gradient, the distance transform and the perimeter ratio of two neighboring nuclei (see, e.g., FIG. 6C).
- FIG. 7 A depicts an image corresponding to the transformed structural marker g M (T" TM 7 ) .
- the membrane 702 exhibits a tubular-like morphology, and regions corresponding to local maxima are in the substantial center or medial axis of the membrane 702, while regions corresponding to local minima are the center of each individual nuclei.
- structural markers corresponding to the membrane and cytoplasm reach a maximum protein expression in the center of the membrane and cytoplasm respectively, while reaching a minimum protein expression in the stroma and nuclei regions, making them suitable to the local and global shape of the membrane and cytoplasm.
- the advantageous approaches of the present disclosure include proposing a shape model for the individual membrane and cytoplasm, where the shape model corresponds to the geometrical model of a two-dimensional image with variations in diameter.
- FIG. 7B shows an image depicting the probability map of the detected membrane 702.
- One proposed approach of the present disclosure detects both membrane and cytoplasm with different thickness.
- this approach is model based and performs analysis at different scales. It is inspired in the geometrical model of a two-dimensional ring, where the scale factor corresponds to the radius of the ring, and the center of the two dimensional ring reaches values that are close to one, while the border of the ring reaches values close to zero.
- Let 0 ⁇ (x, y) ⁇ y) be the ordered eigenvalues of the Hessian matrix at a specific scale.
- a measure for ring-like structures can then be defined by constructing a probability map, where values with maxima probability are assigned to the medial axis of the two-dimensional ring as:
- x that is, x is the ratio of the eigenvalues, and g penalizes when they are
- FIG. 8 A depicts an original multichannel image, with the nuclei 802, cytoplasm 806 and membrane 804, which are represented using cross-hatching corresponding to the blue, green and red channel, respectively.
- FIG. 8B depicts the probability map that corresponds to the detected cytoplasm based on the ring-based model.
- FIG. 8C depicts the probability map that corresponds to the detected membrane based on the ring-based model.
- FIG. 8D depicts the hierarchical segmentation with a non- overlapping rule
- FIG. 8E depicts the hierarchical segmentation with an overlapping rule.
- FIG. 8A depicts a composite image of three channels: nuclei 802 (blue), membrane 804 (red), and 806 cytoplasm (green).
- nuclei 802 blue
- membrane 804 red
- 806 cytoplasm green
- I c (x, y) [ncell, In, Im, lc, lb]
- FIG. 8B represents the probability map of the detected cytoplasm. It is noted that the probability values are maximum in the center of the membrane where there is a variable radius. Similarly, the probability map of the membrane is presented in FIG. 8C. It is noted that the membrane is localized towards the cell border, while the cytoplasm is localized closer to the nucleus. This information is incorporated in a cost function, which maximizes the probability of the hierarchical localization of the subcellular compartments.
- the method can prioritize sub-cellular regions according to different hierarchical combinations of the sub-cellular compartments.
- Example of sub-cellular prioritization are the following: 1) membrane, versus the rest of the regions: membrane has more priority than cytoplasm and nuclei, and nuclei has more priority than cytoplasm, 2) membrane, versus the rest of the regions: membrane has more priority than cytoplasm and nuclei, and cytoplasm has more priority than nuclei.
- FIG. 8D depicts the result of the hierarchical segmentation, where the red region corresponds to the detected membrane within the cell. The green region corresponds to the detected cytoplasm, and the detected nuclei is blue, while the background is in black. In this case, each pixel gets assigned a unique label:
- FIG. 8E depicts the case where pixels belong to different compartments, according to whether they overlap or not. The an intersection of the detected membrane and cytoplasm is shown in Fig. 8E, and in this case, the weights are assigned evenly.
- cell grouping includes identifying individual cells that follow a specific pattern or criteria.
- FIG. 9 depicts the representation and abstraction of an exemplary tissue architecture 900 at the sub-cellular level as a tree data structure.
- the first level 902 of abstraction is the segmentation of the tissue in terms of epithelium and stroma. It is noted that epithelium cells typically are associated with different degrees of cancer.
- the second level 904 of abstraction is the identification of different groups or sub-populations of individual cells (e.g., cells that belong to different glands, cells that belong to red blood cells, among other criteria, etc.). In general, for each group or sub-population, there are spatial, morphological and/or protein expression rules.
- the third level 906 of abstraction is the representation of the tissue at the sub-cellular level in which each individual cell is expressed in terms of sub-cellular compartments (e.g., individual cell segmentation in terms of nuclei, membrane and cytoplasm).
- FIG. 10 is an example of the proposed tissue representation depicted in
- the tissue architecture 1000 is composed of lobes (e.g., epithelium cells) and stroma regions.
- the association rule is defined by the cells that are in the end secretory parts of the main prostatic glands.
- FIG. 10 depicts the lobules 1 of the main prostatic glands 1010, the end secretory parts 2 of the main prostatic glands, and the stroma 3 composed from smooth muscle cells and/or connective tissue.
- leafs terminal nodes
- nodes represent relevant anatomical structures.
- the cellular compartments are specified in terms of nucleus, cytoplasm and associated membrane.
- Systems and methods disclosed herein may include one or more programmable processing units having associated therewith executable instructions held on one or more non-transitory computer readable media, RAM, ROM, hard drive, and/or hardware.
- the hardware, firmware and/or executable code may be provided, for example, as upgrade module(s) for use in conjunction with existing infrastructure (for example, existing devices/processing units).
- Hardware may, for example, include components and/or logic circuitry for executing the embodiments taught herein as a computing process.
- computer-readable medium refers to a non- transitory storage hardware, non-transitory storage device or product or non-transitory computer system memory that may be accessed by a controller, a processor, a
- the "computer- readable medium" may be accessed by a computational system or a module of a computational system to retrieve and/or execute the computer-executable instructions or software programs encoded on the medium.
- the non-transitory computer-readable media may include, but are not limited to, one or more types of hardware memory, non- transitory tangible media (for example, one or more magnetic storage disks, one or more optical disks, one or more USB flash drives), computer system memory or random access memory (such as, DRAM, SRAM, EDO RAM) and the like.
- FIG. 11 is a diagram showing hardware and software components of an exemplary system 1100 capable of performing the processes described herein.
- the system 1100 includes a computing device 1102, which can include a storage device 1104, a network interface 1108, a communications bus 1116, a central processing unit
- the computing device 1102 can also include a display 1120, e.g., a liquid crystal display (LCD), a cathode ray tube (CRT), and the like.
- the storage device 1104 can include any suitable, computer-readable storage medium, e.g., a disk, non-volatile memory, read-only memory (ROM), erasable programmable ROM (EPROM), electrically-erasable programmable ROM (EEPROM), flash memory, field-programmable gate array (FPGA), and the like.
- the computing device 1102 can be, e.g., a networked computer system, a personal computer, a smart phone, a tablet, and the like.
- exemplary embodiments of an engine 1150 programmed to implement one or more processes described herein can be embodied as computer-readable program code stored on one or more non-transitory computer-readable storage device 1104 and can be executed by the CPU 1110 using any suitable, high or low level computing language, such as, e.g., Java, C, C++, C#, .NET, Python, and the like. Execution of the computer-readable code by the CPU 1110 can cause CPU 1110 to implement an exemplary embodiment of one or more processes described herein.
- the engine 1150 programmed and/or configured to perform hierarchical image segmentation analysis.
- the engine 1150 can be programmed and/or configured to implement an embodiment of the process described with respect to FIG. 2 and can generate a graphical or textual representation of the tissue architecture (e.g., FIGS. 9 and 10.
- the engine 1150 can be programmed and/or executed to access image data from data storage (e.g., a non-transitory computer-readable medium).
- the image data can correspond to a multiplexed image of biological tissue that has been sequentially fluorescent stained to manifest expression levels of a plurality of morphological biomarkers in the biological tissue.
- the morphological biomarkers include biomarkers representative of a single type of sub-cellular morphological unit.
- the engine 1150 can be programmed and/or configured to determine a measure of expression levels of a biomarker.
- the measure can be specific to at least one of the one or more sub-cellular morphological units in the one or more cells and can be a mean of the expression levels.
- the engine 1150 can be programmed and/or configured to perform an image segmentation analysis on the image data based on the biomarker expression levels. The analysis can be used to identify locations and configurations of one or more cells in the biological tissue.
- the engine 1150 can be programmed to detect individual cell boundaries in the image data using, for example, supervised shape ranking, unsupervised shape ranking, and/or support vector
- the analysis can also be used to identify locations and configurations of one or more sub-cellular morphological units (e.g., nuclei, cytoplasm, and/or membrane) within the one or more detected/identified cells.
- the engine 1150 can be programmed and/or configured to detect/identify by imposing topological constraints and/or using a probability map to generate a ring-like structure modeling the membrane or the cytoplasm.
- the expression levels of a biomarker in the one or more sub-cellular morphological units can be automatically determined by the engine 1150 at the level of the sub-cellular morphological units.
- the engine 1150 can be programmed and/or configured to perform image segmentation analysis on the image data based on the biomarker expression levels to identify at least one tissue-based region of interest (e.g., a collection of stromal cells or a collection of epithelial cells).
- tissue-based region of interest e.g., a collection of stromal cells or a collection of epithelial cells.
- the biological tissue sections can be grouped by the engine 1150 based on the expression levels of the biomarker in the sub-cellular morphological units.
- the engine 1150 can be programmed and/or configured to perform an analysis to determine a relationship between expression levels of a biomarker in the one or more sub-cellular morphological units and the configurations of the one or more sub-cellular morphological units.
- the engine 1150 can be programmed to render representations of biological units on the display 1120.
- the engine 1150 can be programmed and/or configured to render a hierarchical representation of one or more cells, one or more subcellular morphological units in the one or more cells, and/or at least one tissue-based region of interest.
- pixels of the image data can be associated with a single type of sub-cellular morphological unit in the hierarchical representation using hard segmentation for which each pixel belongs to either: 1) nuclei, 2) membrane, 3) cytoplasm as described herein.
- pixels of the image data can be associated with one or more types of sub-cellular morphological unit in the hierarchical representation using soft segmentation for which a pixel can belong to one or more subcellular compartments (e.g., nuclei, membrane, cytoplasm).
- a pixels of the image data has a first probability that the pixel corresponds to the first type of sub-cellular morphological unit and a second probability that the pixel corresponds to the second type of sub-cellular morphological unit in the hierarchical representation using probability-based segmentation where each pixel has a probability of belonging to either to the nuclei, membrane and cytoplasm.
- a pixel of the image data has a first membership value that the pixel corresponds to the first type of sub-cellular morphological unit and a second membership value that the pixel corresponds to the second type of sub-cellular morphological unit in the hierarchical representation.
- the engine 1150 can be programmed and/or configured to render representations of expression levels of a biomarker in an overlaid manner on the representations of the one or more cells and the one or more sub-cellular morphological units in the one or more cells.
- the engine 1150 can be programmed and/or configured to determine one or more segmentation-quality metrics for the one or more cells.
- the engine 1150 can render the one or more segmentation-quality metrics for the one or more cells on a display in an overlaid manner over the rendering of the one or more cells.
- only a subset of cells among the one or more cells having segmentation-quality metrics that satisfy one or more predefined segmentation quality criteria are rendered. Examples of criteria include morphological measurement of the cell such as cell size, elongation, shape and morphological measurements of the subcellular compartments such membrane, cytoplasm and nuclei area.
- the network interface 1108 can include, e.g., an Ethernet network interface device, a wireless network interface device, any other suitable device which permits the computing device 1102 to communicate via the network, and the like.
- the CPU 1110 can include any suitable single- or multiple-core microprocessor of any suitable architecture that is capable of implementing and/or running the disclosed processes, e.g., an Intel processor, and the like.
- the random access memory 1112 can include any suitable, high-speed, random access memory typical of most modern computers, such as, e.g., dynamic RAM (DRAM), and the like.
- DRAM dynamic RAM
- FIG. 12 is an exemplary client- server environment 1200 for
- the computing system 1200 includes servers 1210, 1211, 1212 operatively coupled to clients 1220, 1221, 1222, via a communication network 1250, which can be any network over which information can be transmitted between devices communicatively coupled to the network.
- the communication network 1250 can be the Internet, Intranet, virtual private network (VPN), wide area network (WAN), local area network (LAN), and the like.
- the environment 1200 can include repositories or databases 1230, 1231, which can be operatively coupled to the servers 1210-1212, as well as to clients 1220-1222, via the communications network 1250.
- the servers 1210-1212, clients 1220-1222, and databases 1230, 1231 can be implemented as computing devices. Those skilled in the art will recognize that the databases 1230, 1231 can be incorporated into one or more of the servers 1210-1212 such that one or more of the servers can include databases.
- embodiments of the engine 1150 and/or segmentation processes described herein can be implemented by a single device, such as server 1210 or client 1220.
- portions of the engine 1150 and/or segmentation processes described herein can be implemented using different devices (e.g., servers, clients, databases) in the communication network 1250 such that one or more of the devices can be programmed and/or configured to implement one or more steps of the segmentation processes.
- the multiplexed digital images can be store in the database 1230 and the engine and/or segmentation processes described herein can be executed by the server 1210.
- a user can access the server 1210 via the client device 1220 to execute the engine and/or segmentation processes described herein.
- the server 1210 can access the multiplexed images from the database 1230 and can perform an embodiment of the processes described herein to output a hierarchical representation of the biological tissue in the multiplexed image, which can be store, for example, in the database 1231.
- FIG. 13 depicts the results of segmentation of the individual structural markers
- FIGS. 13A-C depict images corresponding to the nuclei (FIG. 13 A), membrane (FIG. 13B), and cytoplasm (FIG. 13C).
- FIGS. 13D-F show an overlay of the raw data 1302 (using cross-hatching to represent the color blue) and the detected compartments 1304 ( using cross-hatching to represent the color green).
- FIGS. 13A-C depict nuclei, membrane and cytoplasm images corresponding from Xenograft datasets, respectively.
- FIGS. 13D-F depict overlays of the segmented nuclei, membrane and cytoplasm (green), with the corresponding image channel (blue), and red lines being the cell boundaries.
- FIGS. 14A-F depict images of the segmentation results of individual cell analysis in the epithelium.
- FIG. 14A corresponds to the image T Compartments , where nuclei
- FIG. 14B corresponds to the membrane channel
- FIG. 14C corresponds to the detected cells.
- FIGS. 14E and 14F depict the probability maps corresponding to the membrane and cytoplasm, respectively.
- FIG. 14C depicts the results of the segmentation at sub-cellular level, where pixels are uniquely associated with a compartmental marker. Nuclei 1406, membrane 1404 and cytoplasm 1402 (FIG. 14C).
- FIG. 14A depicts the original image corresponding to subjects from prostrate cancer, with the nuclei 1406 (e.g., using cross-hatching to represent the color blue), membrane 1404 (e.g., using cross-hatching to represent the color green) and cytoplasm 1402 (e.g., using cross-hatching to represent the color red) channels overlaid.
- FIG. 14C depicts detected cell compartments by applying the watershed algorithm, with each color representing an individual cell.
- FIGS. 15A-I and 16A-I were selected as representative samples, where oversaturation was typically present in these datasets. In general, the images of FIGS. 15A-I are less over- saturated as compared to the images in FIGS. 16A-I.
- FIGS. 15A-C depict the channels corresponding to nuclei, membrane and cytoplasm. More particularly, FIGS. 15A-C show Xenograft images corresponding to the nuclei, membrane and cytoplasm. Images corresponding to FIGS. 15D-F are the segmentation results according to exemplary embodiments of the present disclosure.
- FIG. 15G depicts raw data from the study.
- FIG. 15H depicts single cell segmentation according to systems/methods of the present disclosure and in terms of non- overlapping sub-cellular compartments: nuclei 1502 (e.g., using cross-hatching to represent the color blue), membrane 1506 (e.g., using cross-hatching to represent the color red), and cytoplasm 1504 (e.g., using cross-hatching to represent the color green).
- nuclei 1502 e.g., using cross-hatching to represent the color blue
- membrane 1506 e.g., using cross-hatching to represent the color red
- cytoplasm 1504 e.g., using cross-hatching to represent the color green.
- nuclei 1502 e.g., using cross-hatching to represent the color blue
- membrane 1506 e.g., using cross-hatching to represent the color green
- images in FIGS. 16A-I show the results of both segmentation algorithms. More particularly, FIGS. 16A-C show Xenograft images corresponding to the nuclei, membrane and cytoplasm. Images corresponding to FIGS. 16D-F are the segmentation results according to exemplary embodiments of the present disclosure. To visually compare the segmentation from both algorithms, the segmentation results were color-coded in the color images, and where segmentation results according to the systems/methods of the present disclosure would appear in red, while the results using Definiens Developer Version 7 would appear in green, and regions would appear in yellow are where both algorithms coincide (FIGS. 16D-F).
- FIG. 16G depicts raw data from the study.
- FIG. 16G depicts raw data from the study.
- FIG. 16H depicts single cell segmentation according to systems/methods of the present disclosure and in terms of non- overlapping sub-cellular compartments: nuclei 1602 (e.g., using cross-hatching to represent the color blue), membrane 1606 (e.g., using cross-hatching to represent the color red), and cytoplasm 1604 (e.g., using cross- hatching to represent the color green).
- FIG. 161 depicts single cell segmentation using Definiens Developer Version 7: nuclei 1602 (e.g., using cross-hatching to represent the color blue) and membrane 1606 (e.g., using cross-hatching to represent the color green), with the cytoplasm mask not overlaid in this image (see FIG. 16F).
- FIGS. 17AC displays the results from the tissue section corresponding to colon cancer.
- FIG. 17A depicts the DAPI channel.
- FIG. 17B displays the images
- FIG. 17C shows the segmentation results of the systems/methods of the present disclosure, and the nuclei are correctly separated and the membrane detection is correctly detected in the cell borders.
- FIG. 17A displays the nuclei channel.
- FIG. 17B displays an overlay of the morphological channels: nuclei 1702 (e.g., using cross-hatching to represent the color blue), membrane 1706 (e.g., using cross-hatching to represent the color red) and cytoplasm 1704 (e.g., using cross- hatching to represent the color green).
- nuclei 1702 e.g., using cross-hatching to represent the color blue
- membrane 1706 e.g., using cross-hatching to represent the color red
- cytoplasm 1704 e.g., using cross- hatching to represent the color green.
- FIG. 17C shows the results of an exemplary single cell segmentation algorithm according to the present disclosure, where the segmented compartments are: nuclei 1702 (e.g., using cross-hatching to represent the color blue), membrane 1706 (e.g., using cross-hatching to represent the color red) and cytoplasm 1704 (e.g., using cross-hatching to represent the color green).
- nuclei 1702 e.g., using cross-hatching to represent the color blue
- membrane 1706 e.g., using cross-hatching to represent the color red
- cytoplasm 1704 e.g., using cross-hatching to represent the color green
- FIGS. 18A and 18B depict overlays 1800 and 1850, respectively, of the results of the segmentation with the corresponding protein expression.
- FIGS. 18A-B show biomarker expression overlays with the segmented cell showing nuclei 1802, membrane 1806 and cytoplasm 1804 using cross-hatching to distinguish the structures.
- pGSK protein expression FIG. 18A
- Keratin protein expression FIG. 18B
- FIG. 19 depicts an image 1900 of the segmented cells in the overall tissue.
- FIG. 19 is an image showing the results of the segmentation at the sub-cellular level.
- Each cell is localized in the x-y plane with the corresponding compartments.
- Detail statistics 1902 per cell are quantified with respect to each cell for every protein.
- a text file (not shown) can provide a matrix that quantifies the protein expression. More particularly, data can be exported in a text file or the like, where detail statistics 1902 of the protein are estimated in the compartments.
- Exemplary flowcharts are provided herein for illustrative purposes and are non- limiting examples of methods.
- One of ordinary skill in the art will recognize that exemplary methods may include more or fewer steps than those illustrated in the exemplary flowcharts, and that the steps in the exemplary flowcharts may be performed in a different order than the order shown in the illustrative flowcharts.
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Quality & Reliability (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Molecular Biology (AREA)
- Multimedia (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Image Processing (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Image Analysis (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/865,036 US8995740B2 (en) | 2013-04-17 | 2013-04-17 | System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue |
| PCT/US2014/034471 WO2014172527A1 (en) | 2013-04-17 | 2014-04-17 | Systems and methods for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2987142A1 true EP2987142A1 (en) | 2016-02-24 |
| EP2987142B1 EP2987142B1 (en) | 2018-08-15 |
Family
ID=51134239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14736060.6A Active EP2987142B1 (en) | 2013-04-17 | 2014-04-17 | Systems and methods for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8995740B2 (en) |
| EP (1) | EP2987142B1 (en) |
| JP (1) | JP6496709B2 (en) |
| CN (1) | CN105122308B (en) |
| WO (1) | WO2014172527A1 (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8718928B2 (en) * | 2008-04-23 | 2014-05-06 | Verizon Patent And Licensing Inc. | Traffic monitoring systems and methods |
| TWI496112B (en) * | 2013-09-13 | 2015-08-11 | Univ Nat Cheng Kung | Cell image segmentation method and a nuclear-to-cytoplasmic ratio evaluation method using the same |
| US9778263B2 (en) | 2013-11-13 | 2017-10-03 | General Electric Company | Quantitative in situ characterization of biological samples |
| WO2015093518A1 (en) * | 2013-12-18 | 2015-06-25 | コニカミノルタ株式会社 | Image processing device, pathological diagnosis support system, image processing program, and image processing method |
| CA2969038C (en) * | 2014-12-03 | 2023-07-04 | Ventana Medical Systems, Inc. | Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distribution |
| US10234391B2 (en) * | 2015-02-10 | 2019-03-19 | Konica Minolta, Inc. | Biological substance quantitation method, pathological diagnosis support system and recording medium storing computer readable program |
| US9785848B2 (en) | 2015-04-30 | 2017-10-10 | Ge Healthcare Bio-Sciences Corp. | Automated staining and segmentation quality control |
| CA3021538C (en) * | 2015-06-11 | 2023-09-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Systems and methods for finding regions of interest in hematoxylin and eosin (h&e) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images |
| US10019796B2 (en) * | 2015-10-16 | 2018-07-10 | General Electric Company | System and method for blood vessel analysis and quantification in highly multiplexed fluorescence imaging |
| US10083340B2 (en) * | 2016-01-26 | 2018-09-25 | Ge Healthcare Bio-Sciences Corp. | Automated cell segmentation quality control |
| US11132529B2 (en) | 2016-11-16 | 2021-09-28 | Ventana Medical Systems, Inc. | Convolutional neural networks for locating objects of interest in images of biological samples |
| JPWO2018143406A1 (en) * | 2017-02-06 | 2019-12-26 | コニカミノルタ株式会社 | Image processing device and program |
| CN107240093B (en) * | 2017-05-12 | 2020-11-27 | 清华大学 | An automatic diagnosis method for cancerous cells |
| US10789451B2 (en) * | 2017-11-16 | 2020-09-29 | Global Life Sciences Solutions Usa Llc | System and method for single channel whole cell segmentation |
| EP3729371B1 (en) * | 2017-12-22 | 2023-09-06 | Ventana Medical Systems, Inc. | System and method for generating selective stain segmentation images for cell types of interest |
| US10915729B2 (en) * | 2018-02-20 | 2021-02-09 | The Regents Of The University Of Michigan | Three-dimensional cell and tissue image analysis for cellular and sub-cellular morphological modeling and classification |
| CN112703440B (en) | 2018-09-28 | 2022-12-23 | 仪景通株式会社 | Microscope system |
| CN112714888B (en) | 2018-09-28 | 2023-02-17 | 仪景通株式会社 | Microscope system, projection unit, and image projection method |
| CN112714887B (en) | 2018-09-28 | 2024-02-23 | 仪景通株式会社 | Microscope system, projection unit and image projection method |
| EP3988987A4 (en) * | 2018-09-28 | 2023-09-20 | Evident Corporation | Microscope system, projection unit, and image projection method |
| CN112789684B (en) * | 2018-10-01 | 2025-05-09 | 文塔纳医疗系统公司 | Methods and systems for predicting response to PD-1 axis-directed therapy |
| JP7228688B2 (en) | 2018-10-15 | 2023-02-24 | ベンタナ メディカル システムズ, インコーポレイテッド | Image enhancement enabling improved nuclear detection and segmentation |
| KR102209721B1 (en) * | 2018-12-05 | 2021-01-29 | 재단법인대구경북과학기술원 | Methods and apparatus for analyzing single cell motility |
| CN120148643A (en) * | 2018-12-19 | 2025-06-13 | 匹兹堡大学高等教育联邦体系 | Computational system pathology spatial analysis platform for in situ or in vitro multiparametric cellular and subcellular imaging data |
| CN114391162A (en) | 2019-06-07 | 2022-04-22 | 徕卡显微系统Cms有限公司 | System and method for processing biologically relevant data and microscope |
| JP2021124861A (en) * | 2020-02-04 | 2021-08-30 | ソニーグループ株式会社 | Analysis device, analysis method, analysis program, and diagnosis support system |
| CN115836212A (en) | 2020-03-05 | 2023-03-21 | 天篷生物科学有限公司 | Automated fluorescence imaging and single-cell segmentation |
| WO2022059300A1 (en) * | 2020-09-15 | 2022-03-24 | コニカミノルタ株式会社 | Image processing method, image processing device, and image processing program |
| CN112797923B (en) * | 2021-01-05 | 2022-12-30 | 上海交通大学 | Method, system, and medium for correcting center and euler angle of particle diffraction image pattern |
| CN115841441B (en) * | 2021-09-18 | 2025-12-30 | 河北国增网络科技有限公司 | A statistical method for denoising and normalizing multichannel mass spectrometry images |
| JP7711561B2 (en) * | 2021-11-09 | 2025-07-23 | 株式会社島津製作所 | Data Processing System |
| US12505539B2 (en) * | 2022-01-20 | 2025-12-23 | Applied Materials, Inc. | Cell body segmentation using machine learning |
| EP4728471A2 (en) * | 2023-06-13 | 2026-04-22 | Bruker Spatial Biology, Inc. | Method and system of multi-modal sub-cellular segmentation |
| US20250029237A1 (en) * | 2023-07-19 | 2025-01-23 | Hologic, Inc. | Medical image data analysis and visualization |
| CN119941715B (en) * | 2025-04-03 | 2025-06-20 | 南京信息工程大学 | Multiple immunofluorescence image automatic analysis method, medium and program product |
| CN120747521B (en) * | 2025-09-03 | 2025-12-05 | 浙江大学 | IMC image segmentation method based on multichannel cell collaborative segmentation architecture |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7151847B2 (en) | 2001-02-20 | 2006-12-19 | Cytokinetics, Inc. | Image analysis of the golgi complex |
| US7546210B2 (en) | 2000-06-08 | 2009-06-09 | The Regents Of The University Of California | Visual-servoing optical microscopy |
| US6956961B2 (en) * | 2001-02-20 | 2005-10-18 | Cytokinetics, Inc. | Extracting shape information contained in cell images |
| WO2006047502A2 (en) | 2004-10-25 | 2006-05-04 | Brigham And Women's Hospital | Automated segmentation, classification and tracking of cell nuclei in time-lapse microscopy |
| GB0503629D0 (en) | 2005-02-22 | 2005-03-30 | Durand Technology Ltd | Method and apparatus for automated analysis of biological specimen |
| US20070058836A1 (en) | 2005-09-15 | 2007-03-15 | Honeywell International Inc. | Object classification in video data |
| US20090297015A1 (en) | 2005-10-13 | 2009-12-03 | Fritz Jetzek | Method for Detecting Contours in Images of Biological Cells |
| US7933435B2 (en) * | 2005-11-21 | 2011-04-26 | Vala Sciences, Inc. | System, method, and kit for processing a magnified image of biological material to identify components of a biological object |
| GB2433985A (en) | 2006-01-09 | 2007-07-11 | Cytokinetics Inc | Characterization of features within the boundary regions of biological cells |
| US20080032321A1 (en) | 2006-08-07 | 2008-02-07 | General Electric Company | System and methods for analyzing images of tissue samples |
| US8060348B2 (en) * | 2006-08-07 | 2011-11-15 | General Electric Company | Systems for analyzing tissue samples |
| US8712139B2 (en) * | 2008-03-21 | 2014-04-29 | General Electric Company | Methods and systems for automated segmentation of dense cell populations |
| DE102008030874A1 (en) | 2008-06-30 | 2010-01-07 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method and device for determining a contour and a center point of an object |
| US8488863B2 (en) * | 2008-11-06 | 2013-07-16 | Los Alamos National Security, Llc | Combinational pixel-by-pixel and object-level classifying, segmenting, and agglomerating in performing quantitative image analysis that distinguishes between healthy non-cancerous and cancerous cell nuclei and delineates nuclear, cytoplasm, and stromal material objects from stained biological tissue materials |
| US8335374B2 (en) | 2009-08-12 | 2012-12-18 | Genetix Corporation | Image segmentation |
| US20110091081A1 (en) | 2009-10-16 | 2011-04-21 | General Electric Company | Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin |
| US8300938B2 (en) * | 2010-04-09 | 2012-10-30 | General Electric Company | Methods for segmenting objects in images |
| US20110286654A1 (en) | 2010-05-21 | 2011-11-24 | Siemens Medical Solutions Usa, Inc. | Segmentation of Biological Image Data |
| US20120269418A1 (en) | 2011-04-22 | 2012-10-25 | Ge Global Research | Analyzing the expression of biomarkers in cells with clusters |
| US8831327B2 (en) | 2011-08-30 | 2014-09-09 | General Electric Company | Systems and methods for tissue classification using attributes of a biomarker enhanced tissue network (BETN) |
-
2013
- 2013-04-17 US US13/865,036 patent/US8995740B2/en active Active
-
2014
- 2014-04-17 WO PCT/US2014/034471 patent/WO2014172527A1/en not_active Ceased
- 2014-04-17 EP EP14736060.6A patent/EP2987142B1/en active Active
- 2014-04-17 CN CN201480021830.0A patent/CN105122308B/en active Active
- 2014-04-17 JP JP2016509096A patent/JP6496709B2/en active Active
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2014172527A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US8995740B2 (en) | 2015-03-31 |
| EP2987142B1 (en) | 2018-08-15 |
| WO2014172527A1 (en) | 2014-10-23 |
| JP6496709B2 (en) | 2019-04-03 |
| CN105122308A (en) | 2015-12-02 |
| JP2016517115A (en) | 2016-06-09 |
| US20140314299A1 (en) | 2014-10-23 |
| CN105122308B (en) | 2019-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8995740B2 (en) | System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue | |
| Gecer et al. | Detection and classification of cancer in whole slide breast histopathology images using deep convolutional networks | |
| Oktay et al. | Anatomically constrained neural networks (ACNNs): application to cardiac image enhancement and segmentation | |
| Ta et al. | Graph-based tools for microscopic cellular image segmentation | |
| US20250285265A1 (en) | Systems and methods for detecting structures in 3d images | |
| Zidan et al. | SwinCup: Cascaded swin transformer for histopathological structures segmentation in colorectal cancer | |
| Pan et al. | Cell detection in pathology and microscopy images with multi-scale fully convolutional neural networks | |
| JP2021512446A (en) | Image processing methods, electronic devices and storage media | |
| Bhattacharjee et al. | Review on histopathological slide analysis using digital microscopy | |
| JP2017521779A (en) | Detection of nuclear edges using image analysis | |
| CN114565763A (en) | Image segmentation method, apparatus, device, medium, and program product | |
| Gadermayr et al. | CNN cascades for segmenting whole slide images of the kidney | |
| Zaki et al. | Graph-based methods for cervical cancer segmentation: Advancements, limitations, and future directions | |
| Das et al. | 3dSpAn: An interactive software for 3D segmentation and analysis of dendritic spines | |
| Gou et al. | Artificial intelligence multiprocessing scheme for pathology images based on transformer for nuclei segmentation | |
| Huang et al. | Review of cervical cell segmentation | |
| Kromp et al. | Deep Learning architectures for generalized immunofluorescence based nuclear image segmentation | |
| CN118196113A (en) | A liver and tumor segmentation method based on SNAU-Net | |
| CN117392468A (en) | Cancer pathology image classification system, media and equipment based on multi-instance learning | |
| Kadaskar et al. | Image analysis of nuclei histopathology using deep learning: A review of segmentation, detection, and classification | |
| Qin et al. | Medical image segmentation network based on multi-scale cross-attention and wavelet transform | |
| Stegmaier | New methods to improve large-scale microscopy image analysis with prior knowledge and uncertainty | |
| KR102766284B1 (en) | METHOD FOR GENERATING AND TRAINING Densely convolutional spatial attention network for nuclear segmentation of histological images for computational pathology | |
| Rohr et al. | Tracking and quantitative analysis of dynamic movements of cells and particles | |
| Bhardwaj et al. | DLSAC-Net: An automated enhanced segmentation and classification network for lung diseases detection using chest X-Ray images |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20150909 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20160725 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20180403 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 1030633 Country of ref document: AT Kind code of ref document: T Effective date: 20180815 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014030464 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180815 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1030633 Country of ref document: AT Kind code of ref document: T Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181116 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181215 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181115 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181115 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014030464 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20190516 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190417 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190417 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181215 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20201029 AND 20201104 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602014030464 Country of ref document: DE Owner name: LEICA MICROSYSTEMS CMS GMBH, DE Free format text: FORMER OWNER: GENERAL ELECTRIC COMPANY, SCHENECTADY, NY, US Ref country code: DE Ref legal event code: R081 Ref document number: 602014030464 Country of ref document: DE Owner name: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC (N. D. , US Free format text: FORMER OWNER: GENERAL ELECTRIC COMPANY, SCHENECTADY, N.Y., US Ref country code: DE Ref legal event code: R081 Ref document number: 602014030464 Country of ref document: DE Owner name: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC (N. D. , US Free format text: FORMER OWNER: GENERAL ELECTRIC COMPANY, SCHENECTADY, NY, US |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140417 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180815 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20220721 AND 20220727 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602014030464 Country of ref document: DE Owner name: LEICA MICROSYSTEMS CMS GMBH, DE Free format text: FORMER OWNER: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC (N. D. GES. D. STAATES DELAWARE), MARLBOROUGH, MA, US |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230414 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250428 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20250422 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20250424 Year of fee payment: 12 |